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Tracking of Neural Stem Cells in Rats
with Intracerebral Hemorrhage by the
Use of 3T MRI
Objective: To access the feasibility of clinically available 3T MRI to detect the
migration of labeled neural stem cells (NSCs) in intracerebral hemorrhage (ICH)
in a rat model.
Materials and Methods: The ethics committee of our institution approved this
study. ICH was induced by the injection of collagenase type  into the right stria-
tum of ten Sprague-Dawley rats. Human NSCs conjugated with Feridex (super-
paramagnetic iron oxide: SPIO) were transplanted into the left striatum one week
after ICH induction. MRI was performed on a 3T scanner during the first, second,
third, fourth, and sixth weeks post-transplantation. MRI was obtained using coro-
nal T2- and T2*-weighted sequences. Two rats were sacrificed every week after
in vivo MRI in order to analyze the histological findings.
Results: ICH in the right striatum was detected by MRI one and two weeks
after transplantation without migration of the NSCs. There was no migration of the
NSCs as seen on the histological findings one week after transplantation. The
histological findings two weeks after transplantation showed a small number of
NSCs along the corpus callosum. On MRI three weeks after transplantation,
there was a hypointense line along the corpus callosum and decreased signal
intensity in the right periventricular region. Histological findings three weeks after
transplantation confirmed the presence of the hypointense line representing
SPIO-labeled NSCs. MRI four and six weeks after transplantation showed a
hypointense spot in the right periventricular region. The histological findings four
and six weeks after transplantation showed the presence of prominent NSCs in
the right periventricular region.
Conclusion: 3T MRI can detect the migration of NSCs in rats with ICH along
the corpus callosum. Therefore, 3T MRI could be feasible for detecting the migra-
tion of NSCs in the clinical setting of stem cell therapy.
ell therapy using neural stem cells (NSCs) can relieve dysfunctional
neurons with certain growth factors and give rise to neurons, astrocytes,
and oligodendrocytes to replace the injured cells in tumorous conditions,
stroke, and neurodegenerative disease (1 4). Intracerebral hemorrhage (ICH)
represents at least 10% of all strokes in Western populations (5) and a considerably
higher proportion of strokes in the Asian populations (6). Jeong et al. (7) reported that
intravenously transplanted NSCs could enter the rat brain with ICH, undergo
migration, and thus improve functional recovery.
Most techniques for the evaluation of stem cell therapy in animal models require
histological analysis to determine the fate and migration of cells. Therefore, the
number and location of NSCs transplanted into the central nervous system can only be
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Cestimated postmortem, thus permitting observation at only
one point in time. A technique for continuous and non-
invasive detection of the expansion, migration and fate of
the transplanted cells is crucial to develop in order to guide
further advances in neurotransplantation research and
future clinical applications.
Recently, the migration of implanted NSCs can be
detected serially with the use of high magnetic field experi-
mental MR scanners such as 4.7T, 7T or 9.4T (8 11).
Experimental MR scanners provide high-resolution images
and thin slice thickness sufficient to detect a small number
of labeled cells. However, the major drawbacks are a long
scanning time and heat generation. Currently, high
magnetic field MR scanners cannot be used in clinical
practice. Therefore, to assure the localization of NSCs and
to evaluate the therapeutic effect of NSCs in human trials,
labeled NSCs must be detected and monitored on clinically
available MRI. Therefore, the purpose of this study is to
assess the feasibility of clinical 3T MRI equipment to detect
labeled NSCs in ICH in a rat model.
MATERIALS AND METHODS
Preparation of Neural Stem Cells
Immortalized human NSCs using a retroviral vector
carrying v-myc and vascular endothelial growth factor
(HB1.F3.VEGF) were maintained at a density of 1 10
6
cells/100-mm dish (Sarstedt, Sparks, NV) in Dulbecco’s
modified Eagle’s medium with high glucose (DMEM,
Hyclone, Logan, UT) containing 10% fetal bovine serum
(FBS, Hyclone) and 1% penicillin-streptomycin (Hyclone).
Cells were grown to 80% confluence in a 37 humidified
incubator with 5% CO2 and 95% air environment, and
were then harvested in trypsin containing EDTA
(Hyclone). The cells were cultured in 100-mm dishes
(Sarstedt) coated with poly-L-lysine (Sigma, St Louis, MO).
Intracerebral Hemorrhage Model
The Institutional Committee on Animal Research
approved this study. Ten Spraque-Dawley rats (250 300
g; Samtako, Osan, Korea) were used in this study. ICH was
induced by stereotaxic, intrastriatal administration of
collagenase. After an intraperitoneal injection of 1%
ketamine (30 mg/kg) and xylazine hydrochloride (4
mg/kg), the rats were placed in a stereotaxic frame (Lab
Standard
TM, Stoelting, Wood Dale, IL). A burr hole was
made, and a 26-gauge needle was inserted through the
burr hole into the striatum (AP: +1.0 mm, ML:  2.6 mm,
DV:  5.0 mm). ICH was induced by the administration of
collagenase type IV (1  l saline containing 0.23 U, Sigma)
over a period of five minutes. The needle was then gently
removed, the burr hole was sealed with bone wax, and the
wound was sutured. Animals were maintained in separate
cages at room temperature (25 ), with free access to food
and water under a 12-hour light-dark cycle.
Labeling of Neural Stem Cells with SPIO
Super-paramagnetic iron oxide particles (SPIO, Feridex ,
Berlex Imaging, Wayne, IN) were used to label the NSCs
(HB1.F3.VEGF). Protamine sulfate (PS, Sigma) was used
as a transfection agent (TA). Five  g/ l SPIO and 0.25  g/ l
PS were added to the culture medium, which was
incubated at room temperature for 10 minutes with
occasional stirring. The growth medium for HB1.F3.VEGF
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Fig. 1. Prussian blue staining of neural stem cells (objective magnification:  40).
A. Unlabeled neural stem cells without blue spots.
B. SPIO-labeled neural stem cells show blue spots located inside cells, suggesting presence of iron oxide particles.
ABcells was replaced with this solution and was incubated for
48 h. Labeled cells were harvested for transplantation by
gentle trypsinization. To remove excess iron oxide
particles, trypsinized cells were washed in phosphate
buffered saline and the cells were concentrated by centrifu-
gation, resuspended in phosphate buffered saline, and kept
on ice.
Transplantation of Labeled Neural Stem Cells
For transplantation of labeled NSCs, rats were stereo-
taxically fixed under anesthesia with intraperitoneal
injection of 1% ketamine (30 mg/kg) and xylazine
hydrochloride (4 mg/kg) a week after ICH induction. Two
microliters of 1  10
6 labeled NSCs were delivered to the
transplantation site (left striatum) through a Hamilton
syringe using a microinjector (Microinjector model 310
plus, KD Scientific, Holliston, MA) at the speed of 0.5 
l/min. Needles were left in the transplantation site for
several minutes in order to minimize cell damage caused
by negative pressure.
In Vitro MRI
To determine the sensitivity of 3T MRI for the detection
of labeled NSCs, duplicate aliquots of decreasing numbers
of SPIO-labeled NSCs (2  10
5, 5  10
4, 5  10
3, 250)
were injected into a 2% gelatin tube using a microinjector
with a Hamilton syringe. Centrifugation was performed to
remove microbubbles from the gelatin tube. Each of the
gelatin tubes were then placed in a custom-made holder for
the experiments performed using a 3T MR scanner
(Magnetom Tim Trio, Siemens Medical Solutions,
Erlangen, Germany) and clinically available wrist coil. The
imaging parameters were as follows: TR/TE = 231/10
msec, flip angle = 25 , field of view (FOV) = 7.0 cm,
matrix number = 256  192, slice thickness = 2 mm and
number of excitation = 2.0.
In Vivo MRI
Rats with grafted SPIO-labeled NSCs were examined for
period of 1 6 weeks (1, 2, 3, 4, and 6 weeks) post-
transplantation using a 3T MR scanner and clinically
available wrist coil. Rats were anesthetized for imaging
using general inhalation anesthesia (1.5% isoflurane in a
1:2 mixture of O2/N2) during the MRI procedures. To
reduce artifacts during respiration, each rat head was fixed
in the prone position. T2-weighted images (TR/TE =
3,000/100 msec, flip angle = 150 , acquisition time = 2
42 ) and T2*-weighted images (TR/TE = 231/10 msec, flip
angle = 25 , acquisition time = 2 56 ) were obtained.
Other imaging parameters were as follows: FOV = 7.0 cm,
matrix number = 256  192, slice thickness = 2 mm, slice
gap = 0.1 mm and number of excitation = 2.0.
Image Analysis
Image analysis was performed before the pathological
results were known. Two radiologists in consensus
analyzed all images. MR images were reviewed on a
picture archiving and communication systems (PACS;
Marotech, Seoul, Korea) workstation. T2-weighted images
were used for detection of ICH and T2*-weighted images
were used to track the labeled NSCs. The labeled NSCs
were supposed to present as hypointense foci in brain
parenchyma because of a magnetic susceptibility artifact.
One radiologist performed quantitative analysis for all of
the MR images. The change of signal intensity (SI) ratio on
a T2*-weighted image was measured in defined regions of
interest in both periventricular regions.
Histopathological and Immunohistochemical Analysis
After in vivo MRI, two rats were sacrificed by
intravenous injection of pentobarbitone sodium each
week. The brains were removed and fixed for 24 h in 4%
paraformaldehyde. A coronal section was made through
the needle entry site and was then fixed in paraffin.
Sections of 7  m thickness were cut. Hematoxylin and
eosin (H & E) stain, Prussian blue stain, and an immunohis-
tochemical stain using an anti-nestin human specific
monoclonal antibody (Chemicon, Temecula, CA) were
Chang et al.
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Fig. 2. In vitro T2*-weighted images of
neural stem cells.
A-D. 250 neural stem cells in 2% gelatin
tube (A), 5  10
3 neural stem cells (B), 5
10
4 neural stem cells (C), 2  10
5
neural stem cells (D). In B, C, and D,
T2*-weighted images (TR/TE = 231/10
msec) show linear, hypointense cluster in
bottom of tubes (arrows), representing
SPIO-labeled neural stem cells. 
AB C Dused for a histological examination by one pathologist.
Prussian blue stain was used to detect and track the labeled
NSCs. Immunohistochemical staining was used to confirm
the presence of NSCs.
RESULTS
Labeling of Neural Stem Cells
Prussian blue stain was used for the evaluation of labeling
of NSCs. NSCs were efficiently labeled and SPIO located
inside cells was visualized by Prussian blue staining. The
iron oxide nanoparticles in colonies of NSCs in culture were
observed as blue spots on microscopy (Fig. 1).
In Vitro MRI
To check the sensitivity of the MRI technique and to
mimic the signal behavior in brain tissue, we performed in
vitro MRI of labeled cells. NSCs were labeled with SPIO as
described above, and a cell suspension (at concentration of
2  10
5, 5  10
4, 5  10
3, 250 cells/ l) was suspended in
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Fig. 3. MR and histological findings one week after implantation of neural stem cells.
A. T2-weighted image (TR/TE = 3,000/100 msec) shows hypointense, SPIO-labeled, neural stem cells (curved arrow) in left striatum and
hyperintense lesion (arrows) in right striatum, representing intracerebral hemorrhage.
B. T2*-weighted image (TR/TE = 231/10 msec) reveals hypointense, SPIO-labeled neural stem cells (curved arrow) in left cerebral
hemisphere.
C. Hematoxylin and eosin staining (objective magnification:  4) shows intracerebral hemorrhage (arrows) in right striatum with mass
effect to corpus callosum and right lateral ventricle (LV).
D. Prussian blue staining (objective magnification:  4) shows no migration of SPIO-labeled neural stem cells.
E. Immunohistochemical staining (objective magnification:  4) shows no migration of neural stem cells.
CD E2% gelatin. MR images showed a clear hypointense signal
at all concentrations greater than 5  10
3 cells (Fig. 2).
In Vivo MRI and Histopatological Analysis
One week after implantation of NSCs, T2-weighted
imaging showed ICH in the right striatum. Hypointensity
on MRI was found only at the injection site of labeled
NSCs and migration of labeled NSCs was not detected.
Migration of NSCs into the corpus callosum or the right
periventricular region was not seen on the histopathologi-
cal findings (Fig. 3).
On MRI two weeks after implantation, the ICH finding in
the right striatum had not changed. Migration of NSCs did
not occur except a hypointense spot at the injection site of
the NSCs, decreased slightly in size as seen on T2*-
weighted imaging. Prussian blue staining showed fewer
blue spots along the corpus callosum, and immunohisto-
chemical staining confirmed migrating NSCs (Fig. 4).
On MRI three weeks after implantation, T2-weighted
imaging showed a further decrease in the size of ICH in the
Chang et al.
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AB
Fig. 4. MR and histological findings two weeks after implantation of neural stem cells.
A. On T2-weighted image (TR/TE = 3,000/100 msec), size of intracerebral hemorrhage (arrow) in right cerebral hemisphere is smaller
than it was one week after implantation of neural stem cells.
B. T2*-weighted image (TR/TE = 231/10 msec) shows slightly decreased size of hypointense spot (curved arrow) in left cerebral
hemisphere. There is no migration of neural stem cells.
C. Prussian blue staining (objective magnification:  4) shows small number of neural stem cells in corpus callosum (arrows).
D. Immunohistochemical staining (objective magnification:  4) shows migration of small number of neural stem cells into corpus
callosum (arrows).
CDright striatum. T2*-weighted imaging showed a decreased
size of the hypointense spot in the left striatum and linear
hypointensity along the corpus callosum, which is consid-
ered to represent labeled NSCs. There was also a small,
hypointense spot in the right periventricular region.
Prussian blue staining and immunohistochemical staining
showed a large number of labeled NSCs along the corpus
callosum and right periventricular region (Fig. 5).
MRI after four and six weeks showed similar findings of
decreased size of ICH in the right striatum on T2-weighted
imaging and an increased hypointense spot in the right
periventricular region on T2*-weighted imaging. On T2*-
weighted imaging, the hypointense spot in the left striatum
had further decreased in size. Prussian blue staining and
immunohistochemical staining showed labeled NSCs in the
right periventricular region (Fig. 6).
Changes of the SI ratio in the right periventricular region
showed a rapid drop between two and three weeks, which
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Fig. 5. MR and histological findings three weeks after implantation of neural stem cells.
A. T2-weighted image (TR/TE = 3,000/100 msec) shows decreased size (arrow) of intracerebral hemorrhage two weeks after implanta-
tion of neural stem cells.
B. T2*-weighted image (TR/TE = 231/10 msec) shows decreased size of hypointense spot (curved arrow) in left striatum. Linear low
signal intensity (arrows) along corpus callosum is considered to represent SPIO-labeled neural stem cells. There is small, hypointense
spot in right, periventricular region (arrowheads), suggestive of migrated neural stem cells.
C. Prussian blue staining (objective magnification:  2) shows large number of SPIO-labeled, neural stem cells in corpus callosum
(arrows).
D. Immunohistochemical staining (objective magnification:  2) shows neural stem cells in corpus callosum (arrows).
CDwas well correlated with the histological findings of large-
scale migration of labeled NSCs. On the contrary, the SI
ratio at the implantation site of the left striatum gradually
increased (Fig. 7).
DISCUSSION
In our study, clinically available 3T MRI was acceptable to
use for the detection of implanted NSCs crossing the corpus
callosum to the periventricular region, and this finding
correlated with the histopathologic findings. Migration
through the corpus callosum to the lesion site in a stroke
model has been reported in several studies (11, 14 15).
Almost all of the reported studies used experimental MRI (>
4.7T) that enabled in vivo imaging with near microscopic
resolution (9 11, 16, 17). Detection of NSCs using experi-
mental MRI has also been achieved using extremely long
measurement times of several hours to achieve the
Chang et al.
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AB
Fig. 6. MR and histological findings four weeks after implantation of neural stem cells.
A. T2-weighted image (TR/TE = 3,000/100 msec) shows decreased size of intracerebral hemorrhage three weeks after implantation of
neural stem cells.
B. T2*-weighted image (TR/TE = 231/10 msec) shows decreased size of hypointense spot (curved arrow) in left striatum. Clusters of
hypointensity (arrows) are seen in right periventricular region.
C. Prussian blue staining (objective magnification:  4) shows inhomogeneous distribution of neural stem cells around right ventricle
(arrows).
D, E. Immunohistochemical staining (objective magnification:  4 and  10) shows neural stem cells in right, periventricular region
(arrows).
CD Enecessary signal-to-noise ratio and contrast (9, 16).
Contrast agents for monitoring cell migration on MRI can
be divided into two types. One type is an agent containing
gadolinium-diethylenetriamine penta-acetic acid (Gd-
DTPA), and the other type is an agent containing SPIO. As
stem cells labeled with Gd-DTPA can be monitored for up
to seven days after injection, it is not appropriate for long-
term monitoring. Stem cells labeled with SPIO are
appropriate for long-term, in vivo monitoring because of
the stability and high contrast of SPIO (14, 18). We used
SPIO (Feridex ) in our study as it is a contrast agent based
on dextran-coated SPIO nanoparticles and the FDA
clinically approves it as a blood pool agent.
Particles of SPIO can be as small as 7 10 nm and are
located in unmagnetized cell cytosol. SPIO can be
detected with high magnetic MRI T2*- as well as on T2-
weighted imaging because of its susceptibility artifact (14).
SPIO nanoparticles have been used for labeling cells for in
vivo MR cell tracking (15). Frank et al. (14) showed that
magnetic labeling of mammalian cells using ferumoxides
and TAs is possible and may enable cellular MRI and
tracking in both experimental and clinical settings.
However, anionic surface charges of ferumoxides and TAs
transverse negatively charged cell membranes. It is
mandatory to use a TA to promote intracellular incorpora-
tion of SPIO. Labeling a cell with a contrast agent based
on SPIO nanoparticles before transplantation has been
widely investigated for use in human medicine (19 20).
Widely used TAs are poly-L-Lysine (PLL) and protamine
sulfate. PLL is not approved by the FDA and is cytotoxic
at a concentration of 10  M( 2 1 22). 
The FDA has approved the use of protamine sulfate as
an antidote of heparin, and it is safe and effective as a TA
(22). In our study, we could label NSCs effectively with
SPIO and protamine sulfate.
SPIO is detectable with at least 500 cells in a plane by
the use of 4.7T MRI and 100 cells in a plane by the use of
9.4T MRI (10). High magnetic field MRI (> 4.7T) has a
higher sensitivity than 3T MRI for the detection of SPIO
due to the high susceptibility effect of high magnetic field
MRI. In our study, 5  10
3 cells with a 2-mm slice
thickness could be detected on 3T MRI. It is difficult to
compare the results of various reports because the sensitiv-
ity of labeled stem cells varies according to the magnetic
strength, surface coil, and various parameters.
Various routes have been tested for the administration of
NSCs (8 10, 12, 23, 24). A greater number of NSCs were
recruited around the lesion site when ipsilateral
intraparenchymal or intraventricular injection was used
rather than contralateral intraparenchymal injection (2).
There was no difference in the recruited cell numbers
between ipsilateral intraparenchymal injection and
intraventricular injection. This finding was thought to be
due to the greater probability of survival of the normal
parenchyma than of the injured parenchyma. However,
intravenous injection required the use of more stem cells
and increased the risk of occlusive venous disease caused
by thrombus formation and an obstructive lesion or mass
formation in the spleen, kidney, or lung (25, 26). We used
contralateral intraparenchymal injection of NSCs to
increase survival of stem cells and to monitor the
intraparenchymal route of the implanted NSCs (2). The
optimal method of implantation should be further investi-
gated in order to be able to deliver stem cells safely and
effectively in the future.
In our study, MR findings three weeks after implantation
showed hypointensity along the corpus callosum, and a
drop in the SI in the periventricular region, both of which
suggest that migration of NSCs is prominent from two
weeks to three weeks after implantation. A histological
examination showed inhomogenous distribution of the
NSCs at the lesion site, especially in the periventricular
region; this correlated well with the MR findings. Our
results agree with the findings of Hoehn et al. (9), who
reported that SPIO-labeled embryonic stem cells injected
intracerebrally could migrate into an ischemic lesion
induced by occlusion of the middle cerebral artery.
However, in our study, 3T MRI could not detect migration
along the corpus callosum at two weeks after implantation
despite the presence of a small number of NSCs in the
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Fig. 7. Signal intensity ratio changes in MR images of right
periventricular region and of left striatum.
Significant decrease of signal intensity ratio between two weeks
and three weeks after implantation of neural stem cells is seen in
right periventricular region, suggesting massive migration of
SPIO-labeled neural stem cells from left striatum into right
periventricular region.
: SI of the right periventricular region (lesion site) 
: SI of NSCs in the left striatum Chang et al.
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corpus callosum, as detected on the histological findings.
This difference can be explained by the lower spatial
resolution of 3T MRI than experimental high magnetic
field MRI. On 3T MRI, acceptable images could be
obtained with a 2-mm slice thickness as the signal-to-noise
ratio is decreased with a slice thickness less than 2-mm.
Therefore, small numbers of NSCs may not be detectable
on 3T MRI.
In conclusion, we have demonstrated that clinically
available 3T MRI can detect the migration of NSCs along
the corpus callosum in rats with ICH. NSCs were
effectively labeled with SPIO using protamine sulfate as a
TA. NSCs labeled with iron oxide nanoparticles, remained
viable and were able to migrate into an ICH site.
Therefore, in the future, 3T MRI may be useful to monitor
the migration of NSCs in the clinical setting of stem cell
therapy.
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